Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Liver Cirrhosis

Free Subscription Articles published in Intern Med Retrieve available abstracts of 25 articles: HTML format Text format

Single Articles

February 2019
1. NAGAYAMA I, Masuda T, Nakagawa S, Murakami T, et al
   Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease.
   Intern Med. 2019 Feb 1. doi: 10.2169/internalmedicine.2174.
   PubMed     Text format     Abstract available
   
   
   January 2019
2. SATO T, Endo K, Kakisaka K, Suzuki Y, et al
   Decreased Mean Kurtosis in the Putamen is a Diagnostic Feature of Minimal Hepatic Encephalopathy in Patients with Cirrhosis.
   Intern Med. 2019 Jan 10. doi: 10.2169/internalmedicine.2116.
   PubMed     Text format     Abstract available
   
   
   November 2018
3. YAMAUCHI R, Takata K, Shinagawa Y, Tanaka T, et al
   Hepatocellular Carcinoma Arising in a Non-cirrhotic Liver with Secondary Hemochromatosis.
   Intern Med. 2018 Nov 19. doi: 10.2169/internalmedicine.0973.
   PubMed     Text format     Abstract available
   
   
   
4. SEIKE T, Komura T, Shimizu Y, Omura H, et al
   A Young Man with Non-alcoholic Steatohepatitis and Serum Anti-mitochondrial Antibody Positivity.
   Intern Med. 2018;57:3093-3097.
   PubMed     Text format     Abstract available
   
   
   October 2018
5. ICHIKAWA T, Machida N, Kaneko H, Oi I, et al
   C-Reactive Protein can Predict Patients with Cirrhosis at a High Risk of Early Mortality after Acute Esophageal Variceal Bleeding.
   Intern Med. 2018 Oct 17. doi: 10.2169/internalmedicine.1447.
   PubMed     Text format     Abstract available
   
   
   
6. MIYASAKA A, Yoshida Y, Yoshida T, Murakami A, et al
   The Real-world Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir for Hepatitis C Genotype 1.
   Intern Med. 2018;57:2807-2812.
   PubMed     Text format     Abstract available
   
   
   July 2018
7. AKASHI M, Tajiri K, Wada A, Tsuneyama K, et al
   A Patient with Non-alcoholic Steatohepatitis Complicated by Multiple Myeloma.
   Intern Med. 2018;57:2013-2018.
   PubMed     Text format     Abstract available
   
   
   
8. MATSUOKA S, Yamana Y, Ishii T, Kumagawa M, et al
   Portal-systemic Encephalopathy due to Complicated Spleno-renal Shunt Successfully Treated with Balloon-occluded Retrograde Transvenous Obliteration Using a Double Coaxial Balloon Catheter System and Shape-memory Coils.
   Intern Med. 2018;57:1861-1866.
   PubMed     Text format     Abstract available
   
   
   June 2018
9. KAWANO A, Shigematsu H, Miki K, Ichiki Y, et al
   Diabetes Mellitus Prevents an Improvement in the Serum Albumin Level During Interferon-free Sofosbuvir-based Therapy for Chronic Hepatitis C Patients: A Multi-institutional Joint Study.
   Intern Med. 2018;57:1533-1542.
   PubMed     Text format     Abstract available
   
   
   May 2018
10. KAMIO T, Hiraoka E, Obunai K, Watanabe H, et al
    Constrictive Pericarditis as a Long-term Undetermined Etiology of Ascites and Edema.
    Intern Med. 2018;57:1487-1491.
    PubMed     Text format     Abstract available
    
    
    April 2018
11. KASUGA K, Sako M, Kasai S, Yoshimoto H, et al
    A Case of Rat Bite Fever Caused by Streptobacillus moniliformis in a Cirrhotic Patient Initially Presenting with Various Systemic Features Resembling Henoch-Schonlein Purpura.
    Intern Med. 2018 Apr 27. doi: 10.2169/internalmedicine.9856.
    PubMed     Text format     Abstract available
    
    
    
12. KONISHI H, Fukuzawa K, Mori S, Satomi-Kobayashi S, et al
    Anti-mitochondrial M2 Antibodies and Myopathy: Author's Reply.
    Intern Med. 2018;57:1189.
    PubMed     Text format    
    
    
    March 2018
13. HAYASHI M, Abe K, Fujita M, Okai K, et al
    Association between the Serum Sodium Levels and the Response to Tolvaptan in Liver Cirrhosis Patients with Ascites and Hyponatremia.
    Intern Med. 2018 Mar 30. doi: 10.2169/internalmedicine.0629.
    PubMed     Text format     Abstract available
    
    
    
14. KITAGAWA S, Oku D, Okamura K
    Spontaneous Mesenteric-gonadal Shunt in a Patient without Cirrhosis.
    Intern Med. 2018 Mar 9. doi: 10.2169/internalmedicine.0599.
    PubMed     Text format    
    
    
    December 2017
15. IKARASHI Y, Kodama K, Taniai M, Hashimoto E, et al
    The Clinical Difference in the Platelet Counts between Liver Cirrhosis with Nonalcoholic Fatty Liver Disease and Hepatitis C Virus.
    Intern Med. 2017 Dec 21. doi: 10.2169/internalmedicine.9853.
    PubMed     Text format     Abstract available
    
    
    
16. UOJIMA H, Murakami S, Nakatani S, Hidaka H, et al
    Late Relapse after a Sustained Virologic Response at 24 Weeks after Treatment with Daclatasvir and Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b Infection with Liver Cirrhosis.
    Intern Med. 2017 Dec 8. doi: 10.2169/internalmedicine.9671.
    PubMed     Text format     Abstract available
    
    
    
17. NAKATANI R, Murata T, Usui T, Moriyoshi K, et al
    Importance of the Average Glucose Level and Estimated Glycated Hemoglobin in a Diabetic Patient with Hereditary Hemolytic Anemia and Liver Cirrhosis.
    Intern Med. 2017 Dec 8. doi: 10.2169/internalmedicine.9135.
    PubMed     Text format     Abstract available
    
    
    November 2017
18. KOMURA T, Ohta H, Seike T, Shimizu Y, et al
    The Efficacy of Corticosteroid Therapy in a Patient with Nonalcoholic Steatohepatitis Overlapping Autoimmune Hepatitis: A Case Report.
    Intern Med. 2017 Nov 20. doi: 10.2169/internalmedicine.8887.
    PubMed     Text format     Abstract available
    
    
    September 2017
19. KOGISO T, Kobayashi M, Yamamoto K, Ikarashi Y, et al
    The Outcome of Cirrhotic Patients with Ascites is Improved by the Normalization of the Serum Sodium Level by Tolvaptan.
    Intern Med. 2017 Sep 25. doi: 10.2169/internalmedicine.9033.
    PubMed     Text format     Abstract available
    
    
    August 2017
20. HARADA M, Yoneda A, Haruyama S, Yabuki K, et al
    Bullous Pemphigoid Associated with the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin in a Patient with Liver Cirrhosis Complicated with Rapidly Progressive Hepatocellular Carcinoma.
    Intern Med. 2017 Aug 21. doi: 10.2169/internalmedicine.8703.
    PubMed     Text format     Abstract available
    
    
    January 2017
21. CHISHIMA S, Kogiso T, Matsushita N, Hashimoto E, et al
    The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease.
    Intern Med. 2017;56:473-480.
    PubMed     Text format     Abstract available
    
    
    January 2016
22. IWAMOTO T, Maeda M, Hisanaga T, Saeki I, et al
    Predictors of the Effect of Tolvaptan on the Prognosis of Cirrhosis.
    Intern Med. 2016;55:2911-2916.
    PubMed     Text format     Abstract available
    
    
    
23. TAKUMA Y, Fukada Y, Iwadou S, Miyatake H, et al
    Surgical Resection for Hepatocellular Carcinoma with Cardiac Cirrhosis after the Fontan Procedure.
    Intern Med. 2016;55:3265-3272.
    PubMed     Text format     Abstract available
    
    
    
24. HAGIWARA S, Nishida N, Chishina H, Ida H, et al
    Cases with Refractory Ascites and a Delayed Response to Tolvaptan.
    Intern Med. 2016;55:3273-3277.
    PubMed     Text format     Abstract available
    
    
    
25. KOGISO T, Hashimoto E, Ito T, Hara T, et al
    Successful Treatment of Ascites using a Denver(R) Peritoneovenous Shunt in a Patient with Paroxysmal Nocturnal Hemoglobinuria and Budd-Chiari syndrome.
    Intern Med. 2016;55:2957-2963.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: